{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T06:10:55Z","timestamp":1792390255790,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018559","name":"Shenyang Young and Middle-aged Science and Technology Innovation Talent Support Program","doi-asserted-by":"publisher","award":["RC240319"],"award-info":[{"award-number":["RC240319"]}],"id":[{"id":"10.13039\/501100018559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013806","name":"Shenyang Pharmaceutical University","doi-asserted-by":"publisher","award":["YQ202208"],"award-info":[{"award-number":["YQ202208"]}],"id":[{"id":"10.13039\/501100013806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007620","name":"Department of Education of Liaoning Province","doi-asserted-by":"publisher","award":["L222510163001"],"award-info":[{"award-number":["L222510163001"]}],"id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jconrel.2025.114513","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T16:17:57Z","timestamp":1764951477000},"page":"114513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Balancing stability and activation: A pseudoparabolic activity spectrum guides fatty acid chain length optimization in prodrug-albumin nanoparticles"],"prefix":"10.1016","volume":"390","author":[{"given":"Chenxia","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianwen","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonggui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qikun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114513_bb0005","first-page":"1","article-title":"Cancer chemotherapy: A review update of the mechanisms of actions, prospects, and associated problems","volume":"01","author":"Mustapha","year":"2021","journal-title":"BIOMED Nat. Appl. Sci."},{"key":"10.1016\/j.jconrel.2025.114513_bb0010","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrclinonc.2016.64","article-title":"Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect","volume":"13","author":"Bocci","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.114513_bb0015","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2022.01.010","article-title":"Emerging nanomedicines of paclitaxel for cancer treatment","volume":"342","author":"Chen","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114513_bb0020","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41578-021-00315-x","article-title":"Multifunctional biomolecule nanostructures for cancer therapy","volume":"6","author":"Wang","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.114513_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114513_bb0030","doi-asserted-by":"crossref","first-page":"10217","DOI":"10.1021\/jacs.3c14005","article-title":"Nanomedicine remodels tumor microenvironment for solid tumor immunotherapy","volume":"146","author":"Guo","year":"2024","journal-title":"J.Am.Chem.Soc"},{"key":"10.1016\/j.jconrel.2025.114513_bb0035","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2020.07.007","article-title":"Delivering the power of nanomedicine to patients today","volume":"326","author":"Germain","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114513_bb0040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.medj.2022.12.001","article-title":"Cancer nanomedicine toward clinical translation: obstacles, opportunities, and future prospects","volume":"4","author":"Zhang","year":"2023","journal-title":"Med"},{"key":"10.1016\/j.jconrel.2025.114513_bb0045","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1039\/D0BM00558D","article-title":"The regulation of nanomaterials and nanomedicines for clinical application: current and future perspectives","volume":"8","author":"Foulkes","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2025.114513_bb0050","doi-asserted-by":"crossref","first-page":"9994","DOI":"10.1021\/acsnano.2c00128","article-title":"Where is nano today and where is it headed? A review of nanomedicine and the dilemma of nanotoxicology","volume":"16","author":"Domingues","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114513_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116650","article-title":"Dextran methacrylate hydrogel microneedles loaded with doxorubicin and trametinib for continuous transdermal administration of melanoma","volume":"246","author":"Huang","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2025.114513_bb0060","article-title":"Research progress of serum albumin in the field of drug delivery","volume":"2","author":"Ji","year":"2024","journal-title":"J. Interdiscip. Med."},{"key":"10.1016\/j.jconrel.2025.114513_bb0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2022.02.027","article-title":"Aluminum nanoparticles deliver a dual-epitope peptide for enhanced anti-tumor immunotherapy","volume":"344","author":"Bai","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114513_bb0070","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jconrel.2025.01.035","article-title":"Albumin-based delivery systems: recent advances, challenges, and opportunities","volume":"380","author":"Murphy","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114513_bb0075","doi-asserted-by":"crossref","DOI":"10.26599\/NR.2025.94908032","article-title":"Alkanoyl-chain of glyceride modifications in larotaxel to enhance albumin binding for improved safety and antitumor efficacy","volume":"18","author":"Zhao","year":"2025","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2025.114513_bb0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.addr.2017.02.003","article-title":"The battle of \u201cnano\u201d paclitaxel","volume":"122","author":"Sofias","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114513_bb0085","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jconrel.2020.12.035","article-title":"Albumin-binding prodrugs via reversible iminoboronate forming nanoparticles for cancer drug delivery","volume":"330","author":"Hao","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114513_bb0090","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1021\/acs.nanolett.2c04976","article-title":"Structure\u2013activity relationship of pH-sensitive doxorubicin-fatty acid prodrug albumin nanoparticles","volume":"23","author":"Yang","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.114513_bb0095","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.addr.2018.07.011","article-title":"Harnessing albumin as a carrier for cancer therapies","volume":"130","author":"Hoogenboezem","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114513_bb0100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jconrel.2021.09.040","article-title":"SN38-based albumin-binding prodrug for efficient targeted cancer chemotherapy","volume":"339","author":"Huang","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114513_bb0105","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.apsb.2020.12.001","article-title":"Pure redox-sensitive paclitaxel\u2013maleimide prodrug nanoparticles: endogenous albumin-induced size switching and improved antitumor efficiency","volume":"11","author":"Lou","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2025.114513_bb0110","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-45609-0","article-title":"Structural optimization of siRNA conjugates for albumin binding achieves effective MCL1-directed cancer therapy","volume":"15","author":"Hoogenboezem","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114513_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-42399-9","article-title":"NIR-dye bridged human serum albumin reassemblies for effective photothermal therapy of tumor","volume":"14","author":"Shi","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114513_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101454","article-title":"Nanoparticulation of prodrug into medicines for cancer therapy","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.114513_bb0125","article-title":"Stimuli-responsive prodrug chemistries for drug delivery","volume":"1","author":"Taresco","year":"2018","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2025.114513_bb0130","first-page":"242","article-title":"On-demand assembly of polymeric nanoparticles for longer-blood-circulation and disassembly in tumor for boosting sonodynamic therapy","volume":"18","author":"Wen","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2025.114513_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101863","article-title":"On-demand phototoxicity inhibition of sensitizers and H2S-triggered in-situ activation for precise therapy of colon cancer","volume":"50","author":"Wen","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2025.114513_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102275","article-title":"Tailoring modification modules of paclitaxel prodrug nanoassemblies to manipulate efficacy and tolerance","volume":"56","author":"Sun","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2025.114513_bb0145","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-27804-5","article-title":"Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression","volume":"13","author":"Nasibullin","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114513_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-35033-7","article-title":"Hybrid chalcogen bonds in prodrug nanoassemblies provides dual redox-responsivity in the tumor microenvironment","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114513_bb0155","article-title":"Satellite-type sulfur atom distribution in trithiocarbonate bond-bridged dimeric prodrug nanoassemblies: achieving both stability and activatability","volume":"36","author":"Li","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114513_bb0160","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-05786-0","article-title":"Cathepsin B in programmed cell death machinery: mechanisms of execution and regulatory pathways","volume":"14","author":"Xie","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2025.114513_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121887","article-title":"Uncloaking cell-impermeant gold nanorods via tumor microenvironmental cathepsin B facilitates cancer cell penetration and potent radiosensitization","volume":"291","author":"Raghuram","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114513_bb0170","doi-asserted-by":"crossref","first-page":"10271","DOI":"10.1021\/ja0489240","article-title":"Strategy-in-inhibition-of-cathepsin-b-a-target-in-tumor-invasion-and-metastasis","volume":"126","author":"Lim","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.114513_bb0175","article-title":"Light-triggered PROTAC Nanoassemblies for photodynamic IDO proteolysis in cancer immunotherapy","volume":"36","author":"Choi","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114513_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102693","article-title":"Cascade-responsive nano-PROTACs for tumor-specific ALK protein degradation and enhanced cancer therapy","volume":"62","author":"Zhao","year":"2025","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2025.114513_bb0185","doi-asserted-by":"crossref","DOI":"10.1021\/acs.bioconjchem.5c00424","article-title":"Identification of a novel linker enabling the bioconjugation of a cyclic dinucleotide for the STING antibody-drug conjugate TAK-500","author":"Lee","year":"2025","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2025.114513_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1215694","article-title":"Optimizing the enzymatic release of MMAE from isoDGR-based small molecule drug conjugate by incorporation of a GPLG-PABC enzymatically cleavable linker","volume":"14","author":"Zambra","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.114513_bb0195","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1158\/0008-5472.CAN-17-2391","article-title":"Cathepsin B Is dispensable for cellular processing of cathepsin B-cleavable antibody\u2013drug conjugates","volume":"77","author":"Caculitan","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114513_bb0200","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1158\/0008-5472.CAN-22-0787","article-title":"Therapy-induced senescence enhances the efficacy of HER2-targeted antibody\u2013drug conjugates in breast cancer","volume":"82","author":"Duro-S\u00e1nchez","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114513_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122258","article-title":"A novel antibody-KSP inhibitor conjugate improves KSP inhibitor efficacy in vitro and in vivo","volume":"301","author":"Li","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114513_bb0210","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1039\/C8BM00946E","article-title":"A biocompatible and cathepsin B sensitive nanoscale system of dendritic polyHPMA-gemcitabine prodrug enhances antitumor activity markedly","volume":"6","author":"Dai","year":"2018","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2025.114513_bb0215","doi-asserted-by":"crossref","first-page":"11765","DOI":"10.1021\/jacs.9b04272","article-title":"Antitumor activity of 1,18-Octadecanedioic acid-paclitaxel complexed with human serum albumin","volume":"141","author":"Callmann","year":"2019","journal-title":"J.Am.Chem.Soc"},{"key":"10.1016\/j.jconrel.2025.114513_bb0220","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jconrel.2022.05.038","article-title":"Molecular analysis and therapeutic applications of human serum albumin-fatty acid interactions","volume":"348","author":"Linciano","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114513_bb0225","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jcis.2022.10.003","article-title":"Biomimetic nanoprodrugs from fatty acid modified camptothecin and albumin for enhanced pharmacotherapy","volume":"630","author":"Gao","year":"2023","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2025.114513_bb0230","doi-asserted-by":"crossref","first-page":"14217","DOI":"10.1021\/acs.jmedchem.1c00391","article-title":"Role of chain length and degree of unsaturation of fatty acids in the physicochemical and pharmacological behavior of drug\u2013fatty acid conjugates in diabetes","volume":"64","author":"Singh","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.114513_bb0235","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1021\/acsnano.6b04268","article-title":"Blood\u2013brain-barrier-penetrating albumin nanoparticles for biomimetic drug delivery via albumin-binding protein pathways for Antiglioma therapy","volume":"10","author":"Lin","year":"2016","journal-title":"ACS Nano"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925011277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925011277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:21:20Z","timestamp":1781702480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925011277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":47,"alternative-id":["S0168365925011277"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114513","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Balancing stability and activation: A pseudoparabolic activity spectrum guides fatty acid chain length optimization in prodrug-albumin nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114513"}}